Mavenclad (cladribine) is an oral prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS), including relapsing-remitting disease and active secondary progressive disease. It works by selectively targeting and reducing certain types of white blood cells (lymphocytes) that are believed to play a role in the abnormal immune response that damages the protective covering (myelin) of nerves in MS. Mavenclad is typically given in two short treatment courses over two years, offering long-term disease control with limited dosing.<\/p>\n","protected":false},"excerpt":{"rendered":"
Mavenclad (cladribine) is an oral prescription medication used to treat relapsing forms of multiple sclerosis (MS) in adults. It is typically reserved for individuals who have tried other MS medications without success or could not tolerate them. The treatment consists of short-course dosing over two years, with long-lasting\u00a0effects.<\/p>\n","protected":false},"featured_media":151,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[37],"product_cat":[15],"product_tag":[23],"class_list":{"0":"post-152","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_brand-mavenclad","7":"product_cat-uncategorized","8":"product_tag-tablets","10":"first","11":"instock","12":"shipping-taxable","13":"purchasable","14":"product-type-simple"},"yoast_head":"\n